chartexchange

STOK
Stoke Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:53:39 PM EST
26.91USD+0.824%(+0.22)230,782
26.69Bid26.91Ask0.22Spread

STOK Financials

In Q3 FY 2026 (ended ), Stoke Therapeutics, Inc. Common Stock (STOK) reported revenue of $11.26M, net income of −$73.64M, operating cash flow of −$62.69M, and assets of $406.69M (filed ).

Loading financial statements…